NMOSD and MOGAD: an evolving disease spectrum

Tools

Item Type:	Review
Title:	NMOSD and MOGAD: an evolving disease spectrum
Creators Name:	Uzawa, A., Oertel, F.C., Mori, M., Paul, F. and Kuwabara, S.
Abstract:	Neuromyelitis optica (NMO) spectrum disorder (NMOSD) is a relapsing inflammatory disease of the CNS, characterized by the presence of serum aquaporin 4 (AQP4) autoantibodies (AQP4-IgGs) and core clinical manifestations such as optic neuritis, myelitis, and brain or brainstem syndromes. Some people exhibit clinical characteristics of NMOSD but test negative for AQP4-IgG, and a subset of these individuals are now recognized to have serum autoantibodies against myelin oligodendrocyte glycoprotein (MOG) - a condition termed MOG antibody-associated disease (MOGAD). Therefore, the concept of NMOSD is changing, with a disease spectrum emerging that includes AQP4-IgG-seropositive NMOSD, MOGAD and double-seronegative NMOSD. MOGAD shares features with NMOSD, including optic neuritis and myelitis, but has distinct pathophysiology, clinical profiles, neuroimaging findings (including acute disseminated encephalomyelitis and/or cortical encephalitis) and biomarkers. AQP4-IgG-seronegative NMOSD seems to be a heterogeneous condition and requires further study. MOGAD can manifest as either a monophasic or a relapsing disease, whereas NMOSD is usually relapsing. This Review summarizes the history and current concepts of NMOSD and MOGAD, comparing epidemiology, clinical features, neuroimaging, pathology and immunology. In addition, we discuss new monoclonal antibody therapies for AQP4-IgG-seropositive NMOSD that target complement, B cells or IL-6 receptors, which might be applied to MOGAD in the near future.
Keywords:	Aquaporin 4, Autoantibodies, Myelin-Oligodendrocyte Glycoprotein, Neuromyelitis Optica
Source:	Nature Reviews Neurology
ISSN:	1759-4758
Publisher:	Nature Publishing Group
Volume:	20
Number:	10
Page Range:	602-619
Date:	October 2024
Official Publication:	https://doi.org/10.1038/s41582-024-01014-1
PubMed:	View item in PubMed

Repository Staff Only: item control page